🇺🇸 RANCAD in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 9

Most-reported reactions

1. Arthralgia — 1 report (11.11%)
2. Breast Cancer — 1 report (11.11%)
3. Dyspepsia — 1 report (11.11%)
4. Ecchymosis — 1 report (11.11%)
5. Hepatic Infection — 1 report (11.11%)
6. Kidney Enlargement — 1 report (11.11%)
7. Pain In Extremity — 1 report (11.11%)
8. Rash — 1 report (11.11%)
9. Stress — 1 report (11.11%)

Source database →

Frequently asked questions

Is RANCAD approved in United States?

RANCAD does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for RANCAD in United States?

TSH Biopharm Corporation Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.